By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199




GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.

Company News
Medivir AB (MVRBF): Phase II COSMOS Study Results Published In Lancet On World Hepatitis Day 7/28/2014 8:56:00 AM
Medivir AB (MVRBF): FDA Has Granted Priority Review For OLYSIO® In Combination With Sofosbuvir Supplementary New Drug Application 7/15/2014 8:19:07 AM
Beactica Initiates Drug Discovery Collaboration With Medivir AB (MVRBF) 6/10/2014 11:05:26 AM
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014 8:56:08 AM
Resolutions At The Annual General Meetings In Medivir AB (MVRBF) On 8 May 2014 5/8/2014 9:10:21 AM
Medivir AB (MVRBF) Release: A Supplemental New Drug Application Has Been Submitted To The FDA For Simeprevir In Combination With Sofosbuvir 5/7/2014 9:25:23 AM
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014 9:14:45 AM
HemoShear, LLC Enters Into R&D Collaboration With Medivir AB (MVRBF) 4/23/2014 9:02:34 AM
Medivir AB (MVRBF) Release: Good Market Uptake For Simeprevir During The First Quarter 2014 4/15/2014 9:19:58 AM
Medivir AB (MVRBF) Release: Annual Report 2013 4/7/2014 8:51:35 AM